CIK 0001104506
- Large accelerated filer
INSMED Inc
Sign in to watch- Ticker
- INSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- VA
- Entity type
- Operating
- EIN
- 541972729
- Phone
- +1 908-977-9900
- Business address
- 700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,785,602
- in 2 filings, $14.7M under 10b5-1 plans
Net −$17,785,602. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-11 | ALTOMARI ALFRED Director | Grant or award | +14,645 | 43,141 | ||
| 2022-05-11 | ANDERSON ELIZABETH M Director | Grant or award | +14,645 | 42,317 | ||
| 2022-05-11 | Brennan David R Director | Grant or award | +14,645 | 95,521 | ||
| 2022-05-11 | Desjardins Clarissa Director | Grant or award | +14,645 | 35,595 | ||
| 2022-05-11 | LEE LEO Director | Grant or award | +14,645 | 53,265 | ||
| 2022-05-11 | MCGIRR DAVID W J Director | Grant or award | +14,645 | 72,561 | ||
| 2022-05-11 | SCHAFER CAROL Director | Grant or award | +14,645 | 31,905 | ||
| 2022-05-11 | SHAROKY MELVIN MD Director | Grant or award | +14,645 | 242,621 | ||
| 2022-05-11 | SHAROKY MELVIN MD Director | Purchase | +20,000 | $17.20 | $344K | 262,621 |
| 2022-05-11 | Lewis William Chair and CEO | Grant or award | +47,598 | 265,222 | ||
| 2022-05-11 | Lewis William Chair and CEO | Grant or award · Stock Option (right to buy) | +224,450 | 224,450 | ||
| 2022-05-11 | Smith Michael Alexander General Counsel, Senior VP | Grant or award | +14,645 | 52,071 | ||
| 2022-05-11 | Smith Michael Alexander General Counsel, Senior VP | Grant or award · Stock Option (right to buy) | +69,060 | 69,060 | ||
| 2022-05-11 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award | +14,645 | 71,606 | ||
| 2022-05-11 | Schaeffer Orlov S Nicole Chief People Strategy Officer | Grant or award · Stock Option (right to buy) | +69,060 | 69,060 | ||
| 2022-05-11 | Adsett Roger Chief Operating Officer | Grant or award | +27,460 | 149,398 | ||
| 2022-05-11 | Adsett Roger Chief Operating Officer | Grant or award · Stock Option (right to buy) | +129,490 | 129,490 | ||
| 2022-05-11 | Bonstein Sara Chief Financial Officer | Grant or award | +20,137 | 56,116 | ||
| 2022-05-11 | Bonstein Sara Chief Financial Officer | Grant or award · Stock Option (right to buy) | +94,960 | 94,960 | ||
| 2022-05-11 | Flammer Martina M.D. Chief Medical Officer | Grant or award | +21,968 | 68,006 |
Page 52 of 54 · 1,061 trades